Citadel Advisors - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 13 filers reported holding CARDLYTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$57,252,600
+17.4%
84,195,000
-2.3%
0.01%
+20.0%
Q2 2023$48,755,167
+27.9%
86,195,000
-2.8%
0.01%
+25.0%
Q1 2023$38,125,072
-1.9%
88,700,0000.0%0.01%
-11.1%
Q4 2022$38,855,635
-27.9%
88,700,000
-2.7%
0.01%
-25.0%
Q3 2022$53,927,000
-23.0%
91,200,000
-2.5%
0.01%
-33.3%
Q2 2022$70,038,000
-30.2%
93,500,000
-5.1%
0.02%
-14.3%
Q1 2022$100,325,000
+1.9%
98,500,000
+11.3%
0.02%
+5.0%
Q4 2021$98,497,000
+17.7%
88,500,000
+33.1%
0.02%
+17.6%
Q3 2021$83,651,00066,500,0000.02%
Other shareholders
CARDLYTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GUARDIAN POINT CAPITAL, LP 5,000,000$3,783,0002.08%
LINDEN ADVISORS LP 65,612,000$49,513,0000.46%
WOLVERINE ASSET MANAGEMENT LLC 35,978,000$27,036,0000.27%
Teton Advisors, Inc. 1,030,000$779,0000.16%
683 Capital Management, LLC 2,000,000$1,500,0000.11%
CAPSTONE INVESTMENT ADVISORS, LLC 15,000,000$11,316,0000.06%
GABELLI FUNDS LLC 6,920,000$5,234,0000.04%
Citadel Advisors 93,500,000$70,038,0000.02%
GAMCO INVESTORS, INC. ET AL 300,000$227,0000.00%
BARCLAYS PLC 3,141,000$2,344,0000.00%
View complete list of CARDLYTICS INC shareholders